Ledger.Open graph →
SEC Form D · filed March 25, 2025

Cyclacel Pharmaceuticals, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY HEIGHTS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David F. Natan · Berkeley Heights, NJDirectorAvraham F. Ben-Tzvi · Berkeley Heights, NJDirectorAvraham F. Ben-Tzvi · Berkeley Heights, NJDirectorDavid F. Natan · Berkeley Heights, NJDirectorKiu C. Seng · Berkeley Heights, NJExecKwang F. Chong · Berkeley Heights, NJDirectorDatuk Dr. Doris Wong Sing Ee · Berkeley Heights, NJExecAndrea C. Jackson · Durham, NCDirectorJames C. Collins, Jr · Durham, NCDirectorKiu C. Seng · Berkeley Heights, NJExecKwang F. Chong · Berkeley Heights, NJDirectorDatuk Dr. Doris Wong Sing Ee · Berkeley Heights, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗